Senestech (NASDAQ:SNES – Get Free Report) and International Flavors & Fragrances (NYSE:IFF – Get Free Report) are both materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.
Insider and Institutional Ownership
5.2% of Senestech shares are owned by institutional investors. Comparatively, 96.0% of International Flavors & Fragrances shares are owned by institutional investors. 2.2% of Senestech shares are owned by insiders. Comparatively, 1.1% of International Flavors & Fragrances shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
Senestech has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, International Flavors & Fragrances has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Senestech | $2.22 million | 1.65 | -$6.38 million | ($1.37) | -0.49 |
| International Flavors & Fragrances | $10.89 billion | 1.96 | -$361.00 million | $1.09 | 76.68 |
Senestech has higher earnings, but lower revenue than International Flavors & Fragrances. Senestech is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Senestech and International Flavors & Fragrances’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Senestech | -294.73% | -71.89% | -51.98% |
| International Flavors & Fragrances | 2.78% | 7.11% | 3.96% |
Analyst Ratings
This is a summary of current recommendations and price targets for Senestech and International Flavors & Fragrances, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Senestech | 1 | 0 | 0 | 0 | 1.00 |
| International Flavors & Fragrances | 0 | 7 | 12 | 0 | 2.63 |
International Flavors & Fragrances has a consensus target price of $91.40, suggesting a potential upside of 9.35%. Given International Flavors & Fragrances’ stronger consensus rating and higher possible upside, analysts clearly believe International Flavors & Fragrances is more favorable than Senestech.
Summary
International Flavors & Fragrances beats Senestech on 12 of the 14 factors compared between the two stocks.
About Senestech
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
About International Flavors & Fragrances
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B’s Food & Beverage division and the food protection business of N&B’s Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
